300015 爱尔眼科
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)17.58518.90918.04221.95620.960
总资产报酬率 ROA (%)10.92911.83410.42512.42812.566
投入资产回报率 ROIC (%)13.31714.45513.01615.74213.742

边际利润分析
销售毛利率 (%)51.01850.79350.46351.92351.027
营业利润率 (%)27.26024.29421.94023.29222.449
息税前利润/营业总收入 (%)27.53522.70620.74321.69320.597
净利润/营业总收入 (%)22.50217.95016.69216.46515.758

收益指标分析
经营活动净收益/利润总额(%)92.765115.445118.663127.519139.707
价值变动净收益/利润总额(%)8.354-0.723-9.385-9.762-9.367
营业外收支净额/利润总额(%)-2.208-8.722-5.980-11.000-13.156

偿债能力分析
流动比率 (X)1.3701.6941.7991.1501.693
速动比率 (X)1.2051.5451.6631.0591.545
资产负债率 (%)34.69133.66333.72444.05231.456
带息债务/全部投入资本 (%)6.9047.5856.72315.026--
股东权益/带息债务 (%)1,095.811999.5261,147.917438.025426.749
股东权益/负债合计 (%)178.336185.555185.995117.504201.576
利息保障倍数 (X)31.87562.811502.14530.57227.156

营运能力分析
应收账款周转天数 (天)31.45830.77634.62435.1840.000
存货周转天数 (天)33.87329.28829.37426.6030.000